Press Release brought to you by Value Companies

Cure Breast Cancer Foundation Makes International Debut with "New Frontiers in Cancer" Conference in Be'er Sheva, Israel


New Jersey-Based Non-Profit Fundraising Organization Hosts 1ST Annual Event Bringing Together Leading Experts In Breast Cancer Research

CLIFTON, N.J., – Cure Breast Cancer Foundation (CBCF), the non-profit 501 (c) (3) organization which has made tremendous strides assisting breast cancer research in the United States, recently made its mark abroad hosting the 1st annual “New Frontiers in Cancer Research” in Be’er Sheva, Israel.

The International Conference held at the esteemed Soroka Medical Center will serve as a springboard for CBCF’s efforts to expand its fundraising and awareness campaign oversees.

Co-Chaired by Dr. Larry Norton, the Deputy Physician-in-Chief for Breast Cancer Programs and the Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan-Kettering Cancer Center, the event brought together leading experts in various fields of cancer treatment and research to review the results of advanced cancer research.  CBCF is directly responsible for and is actively supporting through its fundraising two of the research projects prominently discussed – breast cancer and its microenvironment and bone metabolism and breast cancer.

CBCF has raised in excess of $4.5 million to assist the dedicated team of physicians and scientists at Memorial Sloan-Kettering Cancer Center in New York and New Jersey and their national and international collaborators, including the research noted previously on bone metabolism and breast cancer at Soroka.  All this work is coordinated by Dr. Norton, CBCF’s scientific advisor, who is leading the fight against breast cancer with groundbreaking work that addresses cases when the disease spreads to other parts of the body where it can currently be controlled, but rarely cured.

Joining Dr. Norton as Co-Chair for “New Frontiers in Cancer Research,” which focused on new ideas that are changing the definition of cancer, was Professor David Geffen, Chief of Breast Oncology Services at Soroka Medical Center. 

“We couldn’t have been more grateful to host ‘New Frontiers in Cancer Research’ which is an incredibly exciting event to introduce our organization and its mission to the International community,” says Andrew Abramson, Treasurer and Co-Founder of the Clifton, N.J.-based CBCF. 

“For the past seven years, we’ve worked tirelessly to raise supporting funds and spread the word about Dr. Norton’s groundbreaking theory of breast cancer ‘self-seeding’ in the United States.  This conference was an opportunity for well-renowned experts to join together and discuss similar methods of treatment and research that are often overlooked, but critically important. It was the perfect platform for us to bring the significant work we’ve been doing with Dr. Norton at home to the International stage.” 

Since its inception in 2007, CBCF has emerged as a leader in breast cancer awareness by raising funds for the research initiative of Dr. Norton and the theory of Self-Seeding.  The Clifton, N.J.-based organization hosts a number of fundraising events and informative seminars throughout the New York metropolitan area and is aggressively expanding its outreach throughout the United States and beyond.

For more information on the CBCF, please call (973) 471-CBCF (2223) or visit

Cure Breast Cancer Foundation

The Cure Breast Cancer Foundation (CBCF) is a Clifton, N.J. – based not-for-profit 501(c) (3) charity devoted to fund research on the growth and spreading of breast cancer cells, also known as the Self-Seeding Theory, at the Memorial Sloan-Kettering Cancer Center in Manhattan and other national and international cancer research facilities under the direction of Dr. Larry Norton, who serves as the Foundation’s Scientific Advisor.  The founder and president is Carly Abramson.  Her father, Andrew Abramson, is Treasurer.  For more information, call (973) 471-CBCF (2223), e-mail or visit

04/16/2014 - 11:13


Value Companies

Want more news about Value Companies? Click here